Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RASQAL: Aliskiren vs Candesartan in CKD
NCT01827202Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Dec 2012
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aliskiren in chronic kidney disease (CKD), hypertension (HTN), proteinuria, sponsored by Medical University of Vienna. Started Dec 2012; status: completed.
02
Drugs
aliskiren
03
Conditions
chronic kidney disease (CKD)hypertension (HTN)proteinuria
Beyond the preview
Go deeper on NCT01827202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01827202.